Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and SCAN domain containing 2 pseudogene (ENSG00000277513) is a non-coding genomic locus classified as a pseudogene related to the functional zinc finger and SCAN domain containing 2 (ZSCAN2) gene. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to frameshifts, premature stop codons, or lack of regulatory elements. As such, this pseudogene does not encode an active transcription factor, does not participate in gene regulation, and has no established role in disease, drug response, or biomarker development. ZSCAN2 itself, like other ZSCAN family members, is a C2H2-type zinc finger and SCAN domain-containing transcription factor involved in control of gene transcription and cellular processes including differentiation and proliferation, but these properties do not apply to pseudogenes such as ENSG00000277513[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and SCAN domain containing 2 pseudogene.